http://orcid.org/0000-0001-6693-6061
References
- Anadón, A., et al., 2014. The role of in vitro methods as alternatives to animals in toxicity testing. Expert Opinion in Drug Metabolism & Toxicology, 10, 67–79.
- Bartosova, L., et al., 2006. The acute toxicity of acetylcholinesterase reactivators in mice in relation to their structure. Neurotoxicity Research, 9, 291–296.
- Berberich, J.A., et al., 2016. Biological testing of organophosphorus-inactivated acetylcholinesterase oxime reactivators identified via virtual screening. Chemical Research in Toxicology, 29, 1534–1540.
- Brodniewicz, T. and Grynkiewicz, G., 2010. Preclinical drug development. Acta Poloniae Pharmaceutica, 67, 578–585.
- Geoghegan, J. and Tong, J.L., 2006. Chemical warfare agents. Continuing Education in Anaesthesis Critical Care & Pain, 6, 230–234.
- Gerets, H.H.J., et al., 2009. Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach. Toxicology In Vitro, 23, 319–332.
- Gerets, H.H.J., et al., 2012. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biology and Toxicology, 28, 69–87.
- Jost, P., et al., 2017. Protective potential of different compounds and their combinations with MESNA against sulfur mustard-induced cytotoxicity and genotoxicity. Toxicology Letters, 275, 92–100.
- Kassa, J., 2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. Journal of Toxicology. Clinical Toxicology, 40, 803–816.
- Kassa, J., et al., 2008a. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats. Chemico-Biological Interactions, Proceedings of the IX International Meeting on Cholinesterases, 175, 425–427.
- Kassa, J., et al., 2008b. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology, 243, 311–316.
- Kassa, J., et al., 2008c. The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun. Mini-Reviews in Medicinal Chemistry, 8, 1134–1143.
- Kuca, K., et al., 2010. Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesterase. Journal of Enzyme Inhibition and Medicinal Chemistry, 25, 509–512.
- Lundy, P.M., et al., 2005. The pharmacokinetics and pharmacodynamics of two HI-6 salts in swine and efficacy in the treatment of GF and soman poisoning. Toxicology, 208, 399–409.
- Martinez-Serra, J., et al., 2014. xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies. OncoTargets and Therapy, 7, 985–994.
- Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55–63.
- Musilek, K., et al., 2007. Design of a potent reactivator of tabun-inhibited acetylcholinesterase–synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203). Journal of Medicinal Chemistry, 50, 5514–5518.
- Ozdemir, A., and Ark, M., 2014. xCELLigence real time cell analysis system: a new method for cell proliferation and cytotoxicity. Niche Journal, 2, 15–17.
- Pejchal, J., et al., 2008. The influence of acetylcholinesterase reactivators on selected hepatic functions in rats. Basic & Clinical Pharmacology & Toxicology, 103, 119–123.
- Piyathilaka, P., et al., 2016. Comparative cytotoxicity of selected cyanotoxins on human embryonic kidney (HEK-293) and human kidney adenocarcinoma (ACHN) Cells. Research Gate, 2, 45–49.
- Riss, T. L., et al., 2004., Cell viability assays. In: Sittampalam, G.S., et al., eds. Assay guidance manual. Bethesda, MD: Eli Lilly & Company and the National Center for Advancing Translational Sciences, 1--34.
- Shahraki, S., et al., 2016. Effect of total hydroalcholic extract of Nigella sativa and its n-hexane and ethyl acetate fractions on ACHN and GP-293 cell lines. Journal of Traditional and Complementary Medicine, 6, 89–96.
- Soldatow, V.Y., et al., 2013. In vitro models for liver toxicity testing. Toxicology Research, 2, 23–39.
- Worek, F. and Thiermann, H., 2013. The value of novel oximes for treatment of poisoning by organophosphorus compounds. Pharmacology & Therapeutics, 139, 249–259.